An acute administration of phenylalanine to neonatal animals has been reported to result in large decreases in the intracellular concentrations of several essential amino acids in neural tissue, as well as an inhibition of neural protein synthesis. The present report evaluates the effects of the loss of amino acids on the concentrations of aminoacyl-tRNA in vivo, with the view that an alteration in the concentrations of specific aminoacyl-tRNA molecules could be the rate-limiting step in brain protein metabolism during hyperphenylalaninaemia. tRNA was isolated from saline-and phenylalanine-injected mice 30-45mi ;after injection, by using a procedure designed to maintain the concentrations of aminoacyl-tRNA present in vivo. Periodate oxidation of the non-acylated tRNA and aminoacylation with radioactively labelled amino acids was used to determine the proportion of tRNA that was present in vivo as aminoacyl-tRNA. Although decreases in ,the intracellular concentrations of alanine, lysine and leucine were observed after phenylalanine administration, the concentrations of alanyl-tRNA, lysyl-tRNA and leucyl-tRNA actually increased by 15 %. Although tryptophan has been suggested to be rate-limiting during hyperphenylalaninaemia, the proportion of tryptophan tRNA that was acylated was maximal in both normal and hyperphenylalaninaemic animals>. This unexpected increase in aminoacyl-tRNA concentration is discussed as perhaps a secondary effect resulting from the phenylalanine-induced inhibition of protein synthesis. In contrast, the proportion ofmethionine tRNA that was acylated in vivo after phenylalanine administration was demonstrated to be decreased by approx. 17 %. When the isoaccepting species of methionine tRNA were separated by reverse-phase column chromatography, three species were separated, one of which was demonstrated to be the initiator species, tRNA,fCt, by the selective aminoacylation and formylation with Escherichia coli enzymes. After the administration of phenylalanine, the acylation of each of the three methionine tRNA species was decreased, with the initiator species being lowered by 10%Y.
The. developing brain of humans and animals has been shown to be markedly affected by a chronic excess -of phenylalanine in the blood circulatory system (Waisman et al., 1960; Schlesinger et al., 1969) . Long-term excesses of phenylalanine have been associated with deficiencies in the total myelin content, both in the human phenylketonuric patient (Menkes, 1968; Shah et aL, 1972b) , and in experimentally induced hyperphenylalaninaemia in animals (Prensky et al., 1971; Shah et al., 1972a) . In addition to chronic conditions associated with phenylketonuria, acute administration of phenylalanine has been shown to affect brain protein metabolism. It has been demonstrated that the administration of phenylalanine causes 'diaggegation' of brain polyVol. 162 ribosomes (Aoki & Siegel, 1970; Siegel et al., 1971; Maclnnes & Schlesinger, 1971; Taub & Johnson, 1975) , which results in an increase in 80S monoribosomes. This increase in 80S monoribosomes was shown to be the result of a decrease in the rate of initiation of brain protein synthesis, since the released ribosomes were vacant couples and not boundto mRNA or peptidyl-tRNA (Taub &Johnson, 1975) . Although the balance between initiation and termination of polypeptide synthesis appeared to be shifted by the introduction of phenylalanine, the exact mechanism responsiblefor this phenomenon at the translational level was unknown.
In addition to the effect on brain polyribosomes, phenylalanine has been shown to cause a decrease in the intracellular concentration of several amino acids. As demonstrated by McKean et al. (1968) and Hughes & Johnson (1976a) , the exposure of neural tissue to high concentrations of phenylalanine lowered the concentrations of most other amino acids, and particularly, the large neutral amino acids, i.e. leucine, isoleucine, valine, tryptophan and methionine. The alterations in the concentrations of these amino acids, some of which are normally present at very low concentrations in neurAl tissue, has often been suggested as the primary reason for the inhibition of protein synthesis by phenylalanine (Appel, 1970; McKean et al., 1968; Aoki & Siegel, 1970; Siegel et al., 1971) .
There have been suggestions that phenylalanine may interfere with the enzymic activation, and subsequent acylation, of other amino acids to tRNA (Roscoe et al., 1968; Appel, 1970 ). An inhibition of the aminoacylation reaction might alter the concentrations ofthis essential precursor (aminoacyl-tRNA) for protein synthesis. The present investigation was directed towards a direct measurement of the effects of phenylalanine on the concentrations of several species of aminoacyl-tRNA in vivo, with the view that this might provide an explanation of the mechanism responsible for the inhibition of initiation events in neonatal brain tissue. Administration ofphenylalanine L-Phenylalanine, dissolved in 0.15M-NaCl to a final concentration of 30mg/ml, was prewarmed to 37°C before injection and was administered by intraperitoneal injection at a dose of 2mg of phenylalanine per g body weight. Control animals matched for age and weight (all animals in this study were 1-8 days old) were injected with a comparable volume of 0.15M-NaCl (60p1/g body weight).
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Preparation ofaminoacyl-tRNA tRNA was isolated from-the injected animals between 30 and 45min after injection. This time period has been shown to be the period in which to observe the optimal effects of phenylalanine on brain protein synthesis (Taub & Johnson, 1975) . Aminoacyl-tRNA was isolated by the procedure described by Allen et al. (1969) , as modified by Johnson & Chou (1973) . To minimize deacylation of aminoacyltRNA during the isolation, whole brains of Swiss albino mice were quickly removed and immediately placed into a Waring blender containing 1 vol. of sodium acetate buffer (150mM-NaCl/50mM-sodium acetate, pH5.1)at4°C, 1 vol. ofphenol(saturatedwith the sodium acetate buffer) and 1mg of bentonite/mi. After the addition of each brain, the tissue was immediately homogenized and the final homogenate was centrifuged (2000g for 15min) to separate the phenol and aqueous phases. The aqueous phase was deproteinized further by two additional treatments with phenol (30ml) and finally with chloroform plus 1 % (v/v) 3-methylbutan-1-ol (30ml). The nucleic acids from the final aqueous layer were precipitated with 2vol. of ethanol at -20°C. Ribosomal RNA was removed from this nucleic acid fraction by precipitation with 1M-NaCl (5ml). The tRNA fractions were resuspended in sodium acetate buffer (2ml) and divided into two equal portions, one ofwhich was treated with a 100-fold molar excess of NaIO4 to oxidize the non-acylated tRNA. The other portion received distilled water and was to be used as a meas-ure of total acceptor activity. To allow complete oxidation of the non-acylated tRNA, the samples were incubated for 15min, in the dark, at room temperature (250C). The oxidized and control preparations were precipitated with ethanol and dialysed against glass-distilled water overnight. These were precipitated once again with 2vol. of ethanol and deacylated by incubation for 3h at 370C in Tris/HCl buffer, pH9.0. The preparations were reprecipitatedwith ethanol, resuspended in a high-salt buffer [0.5M-NaCI/0.05M-MgCl2 /0.01 M-Tris/HCI (pH7.4)] (1 ml), and 100lg of deoxyribonuclease was added to remove any contaminating DNA in the solution. After a 2h incubation at room temperature, the aqueous layer was deproteinized with 1 vol. of phenol and 1 vol. of chloroform. After repeated precipitations to wash the tRNA, the solution was dissolved in a small volume (approx. 1 ml) of water, and the A260 was determined. The tRNA samples were stored at -200C until their use for the measurement of amino acid-acceptor activity.
Aminoacyl-tRNA synthetases Mouse brain aminoacyl-tRNA synthetases were prepared from the postmicrosomal fractions of mouse brain tissue (Johnson & Chou, 1973 (Johnson, 1969 (v/v) glycerol, and the column was washed with the same buffer after the addition of all of the enzyme preparation. The mixture of synthetases was eluted with a solution containing 250mM-potassium phosphate (pH6.5), 20mM-2-mercaptoethanol, 10mM-MgCI2 and 10% glycerol. The fractions containing the peak of protein were pooled (120ml), concentrated by using an Amicon filtration apparatus with a PM-10 filter and then dialysed overnight against a solution containing 2mM-potassium phosphate (pH7.0), 40nmm-2-mercaptoethanol and 10 % glycerol.
The total protein present was determined as above and the enzyme preparation was mixed with an equal volume of glycerol and stored at -85°C.
Aminoacylation of tRNA
The aminoacylation of tRNA was carried out in a reaction mixture (0.5ml) containing 20mM-Tris/HCI, pH7.2, 14.3mM-2-mercaptoethanol, 6jumol each of 19 non-radioactive amino acids, 0.35-1.3 A260 units of tRNA, 0.18-0.32mg of synthetase protein, 1-2,Ci of '4C-labelled amino acids and the optimal concentrations of ATP, CTP and MgCI2 as outlined in Table 1 . The reaction mixtures were incubated for 40min at 37°C and terminated by the addition of 2vol. of ethanol and 10mg of glycogen carrier. The precipitates were collected by centrifugation (100Og for 10min), washed, reprecipitated twice and finally Vol. 162 collected on glass-fibre filters. The amount of radioactivity on each ifiter was determined in a Beckman LS-100 liquid-scintillation system (Hughes & Johnson, 1976a ) with a counting efficiency of more than 95% for 14C.
The aminoacylation of mouse brain methionine tRNA with E. coil enzymes was carried out in a reaction mixture (0.5ml) containing 20mM-Tris/HCl (pH7.2), 5mM-MgCl2, 1.25 mM-ATP, 0.1 mM-CTP, 19 non-radioactive amino acids, each at 6pum, 5mg of E. coli enzymes, 0.5-1.0 A260 unit of tRNA and 1 pCi of [14C]methionine. The reaction mixture was incubated for 30min at 37°C and then deproteinized by phenol and chloroform extraction and washed by ethanol precipitation as described above, ready for chromatography on the RPC-5 column.
Reverse-phase (RPC-5) column chromatography Chromatography was performed as described by Kelmers & Heatherley (1971) . tRNA from each preparation was acylated as described above, deproteinized by phenol and chloroform extraction and washed by repeated precipitation with ethanol.
Approx. 5000-10000c.p.m. of [14C]methionyl-tRNA in sodium acetate buffer was layered on the column (1.Ocmx28cm), and the tRNA was eluted at 250C by a 200ml linear salt gradient (0.4-0.7M-NaCI) in a buffer consisting of 10mM-sodium acetate, 10mM-MgCI2 and 2mM-2-mercaptoethanol (pH4.5). Fractions (1.Oml) were collected, and the amount of radioactivity in each fraction was determined as described above. The refractive index of various fractions was measured to determine the linearity of the gradient and the salt concentration at which each peak of [14C]methionyl-tRNA was eluted from each column. The recovery of radioactivity from the RPC-5 columns was 92-105 %. [14C]formyltetrahydrofolate was eluted from the column with a linear gradient from 0.05 to 0.25M-ammonium acetate (pH8.0) in a buffer containing 0.10M-2-mercaptoethanol. The desired compound was eluted in the final fractions of the gradient, which were pooled, freeze-dried, resuspended in 0.10M-2-mercaptoethanol and freeze-dried again.
The sample was dissolved in 0.1OM-HCI and stored in a desiccator jar at -20°C as the stable 5,10-methenyl derivative. Small portions were diluted with 0.1M-Tris/HCI containing 0.2M-2-mercaptoethanol just before its use, and the pH was adjusted to 7.5 to convert the material into the l1-formyl derivative.
Aminoacylation and formylation of mouse brain tRNAA4* The formylation of mouse brain tRNA, et was performed essentially by the procedure described by Samuel et al. (1970) . The reaction mixtures (0.5ml) included Tris/HCI (pH7.2) (20mM), MgCI2 (5mM), ATP (2.5mM), ammonium acetate (10mM), Lmethionine (0.2mM), E. coli enzymes, 5mg of protein 0.5-1.0 A260 unit of mouse brain tRNA 'and 10-
[14C]formyltetrahydrofolate, 0.5piCi. The mixture was incubated for 30min at 37°C, and then deproteinized by phenol and chloroform extraction and was washed by ethanol precipitation ready for reverse-phase chromatography on RPC-5 columns.
Results

Aminoacylation reaction conditions
The periodate-oxidation technique provides a reliable method for the determination of the portion of tRNA molecules which are present as aminoacyltRNA in vivo. The periodate-oxidation step of the tRNA isolation will oxidize the terminal ribose sugar residue of a non-acylated tRNA molecule, such that the tRNA molecule will no longer accept amino acids. After subsequent deacylation of the tRNA, the total amount of tRNA in the preparation can be determined through the use of radioactively labelled amino acids. The tRNA sample that was not treated with periodate provides a means of determining the total tRNA acceptor activity for each specific amino acid. From the proportion of total tRNA that is resistant to periodate oxidation can be estimated the concentration of precursor available as aminoacyl-tRNA (Allen et al., 1969; Johnson & Chou, 1973 ).
*Abbreviations: tRNAM4', non-acylated methionine tRNA species that can be formylated with E. coli enzyme, i.e. the initiator species; tRNA"ct, non-acylated methionine tRNA that cannot be formylated, i.e. the internal methionine tRNA; Met-tRNA'fet or Met-tRNAmet, acylated isoaccepting species; fMet-tRNAmet, the acylated and formylated methionine tRNA initiator species.
Since a study of the precursor tRNA concentrations is dependent on the acylation of all of the tRNA with radioactive amino acids, the optimal conditions for the aminoacylation reactions were first determined. This was particularly important, since previous work (Johnson & Chou, 1973) has shown that the optimal acylation of brain tRNA with various amino acids is dependent on the concentrations of ATP, CTP, Mg+ and synthetase protein used in the reaction. Therefore appropriate concentrations of deacylated tRNA were incubated in vitro in the reaction mixtures,"and the effect of various concentrations of ATP, CIP, Mg2+ and synthetase enzyme on the aminoacylation for each amino acid was tested. A summary ( Table 1 ) of some of these data reveals some rather striking differences in the optimal conditions for the aminoacylation reaction for these amino acids. In particular, the Mg2+ concentration for maximum acceptance of lysine, leucine and alanine was 7-fold greater than that measured for tryptophan and methionine. In addition, the activities of individual mouse brain synthetases were determined for each amino acid used in this study, so that the concentration of synthetase enzyme was used at a saturating concentration. In a typical reaction, the amount of aminoacyl-tRNA formed was dependent only on the amount of tRNA added (Fig. 1) .
Effects of phenylalanine on tRNA concentrations and amount ofacylation Preliminary results indicated that the total acceptor activity as well as the proportion of tRNA isolated as aminoacyl-tRNA differed considerably for each amino acid (Table 2 ). The aminoacylation reactions provided a comparison between the highly acylated methionyl-tRNA (91 %) and the somewhat lower extent of acylation measured for alanine and lysine (each approx. 80%) for this single tRNA preparation. The aminoacylation reactions, as described in the Materials and Methods section, were used to determine the amount of (a) alanyl-tRNA, (b) lysyl-tRNA and (c) methionyl-tRNA present, by using the appropriate 14C-labelled,amino acid. The amounts of total tRNA (-) and the periodate-resistant tRNA (o) were both determined for each tRNA preparation. Table 2 . Effects ofphenylalanine on the amounts andthe extent ofacylation ofvarious aminoacyl-tRNA species The reaction mixtures, as listed in the Materials and Methods section, were used to determine the amount of aminoacyl-tRNA present for the periodate-resistant tRNA and the total tRNA present for one preparation from saline-injected animals and one preparation from phenylalanine-injected animals. The amount of tRNA present is expressed as pmol of aminoacyl-tRNA formed per A260 unit of tRNA±s.E.M., and the number of independent measurements for each individual preparation is indicated in parentheses.
Amount of aminoacyl-tRNA tRNA preparations from the brains of animals injected with phenylalanine were compared with the tRNA isolated from control animals with respect to the amounts and extent of acylation of five different aminoacyl-tRNAspecies (Table 2) . Although some differences in the tRNA-acceptance activity were detected in the different tRNA preparations, no significant decreases were detected in the amounts of total tRNA available for a specific amino acid after the administration of phenylalanine. However, when the proportions of tRNA available as aminoacyl-tRNA were compared, some very interesting differences were detected. These preliminary results were extended to include several preparations Vol. 162 of tRNA from young animals in order to measure the effects of phenylalanine on the concentrations of aminoacyl-tRNA in vivo.
In general, as indicated by the summary of Table 3 , a state of hyperphenylalaninaemia produces an increase in the acylation of most amino acid tRNA species. This is particularly surprising, since high concentrations of phenylalanine actually decrease the intracellular concentrations of most of these amino acids in brain cells (McKean et al., 1968; Hughes & Johnson, 1976a Table 3 . Summary ofthe effects ofphenylalanine on the acylation ofvarious amino acids The acylation of the tRNA preparations in control and in hyperphenylalaninaemic mice were determined as described in the Materials and Methods section. The values are presented as the mean % of the total tRNA isolated as aminoacyl-tRNA± 1 S.D., with the numbers of independent tRNA preparations in parentheses where appropriate. When only two independent tRNA samples were tested for either the control or hyperphenylalaninaemic animals, then the mean is reported with actual values for individual preparations given in parentheses. Each of the preparations was assayed several times for tRNA-acceptor activity as demonstrated by the measurements listed in (Tables 2 and 3 ). Thus, for the first four aminoacyl-tRNA species studied, either no significant change (tryptophan) or an increase in the aminoacyl-tRNA was observed (as with leucine, lysine and alanine), and the increase for the latter three amino acids was very similar.
Methionine tRNA was the only tRNA species studied that showed any significant decrease in its acylation in vivo. An average decrease of 17 % of the amount of tRNA present in the aminoacylated form was demonstrated for all tRNA preparations from hyperphenylalaninaemic animals. This decrease was the only indication that the concentration of a direct precursor for protein synthesis was lowered in the animals injected with phenylalanine.
The decrease in the amounts of methionyl-tRNA may be of particular importance in the present study, since Met-tRNAf et has been demonstrated to be an integral part of the initiation complex in both prokaryotic and eukaryotic cells (Schreier & Staehelin, 1973; Gupta et al., 1975; Smith & Henshaw, 1975) . Since the study by Taub & Johnson (1975) suggested that the initiation of protein synthesis may be rate-limiting during hyperphenylalaninaemia, it appeared that the acylation of the initiator, tRNAf et, could represent an important regulatory site of protein synthesis which might be altered by high concentrations of phenylalanine.
Separation of the isoaccepting species of methionine tRNA
Reverse-phase column chromatography was used to resolve the isoaccepting methionine tRNA species present in mouse brain tissue and to determine the extent of acylation of each isoaccepting species. The tRNA preparations from normal and hyperphenylalainnaemic mice were acylated essentially as described above, except that 3ml of reaction mixtures was utilized to provide sufficient amounts of [14C]methionyl-tRNA for chromatography. The acylated tRNA was extracted with phenol and collected by repeated ethanol precipitation as described in the Materials and Methods section. The methionyl-tRNA species were separated by reverse-phase column chromatography by using RPC-5 (Kelmers & Heatherley, 1971) . A typical separation of mouse brain methionyl-tRNA on RPC-5 by using a linear NaCl gradient to elute the tRNA from the column is shown in Fig. 2 . Three discrete peaks of brain methionyl-tRNA were resolved by this procedure. This profile is similar to that observed for other eukaryotic systems by using this same chromatographic material (Caskey et al., 1967; Yang et al., 1969; Crystal et al., 1972; Wang et al., 1974) .
The three isoaccepting methionine tRNA species were further characterized to determine which of these is the initiator species, tRNAmCt. Several (Bhaduri et al.' 1970; Crystal et al., 1972; Stanley, 1972; Samuel et al., 1973 (Fig. 3 ). It appears that the first tRNA species eluted from the column is the initiator, Met-tRNAmet, and the other species are the internal methionyl-tRNA molecules.
In addition, the initiator species Met-tRNA,f et, can be formylated by an E. coli transformylase, whereas the internal methionyl-tRNA species (MettRNAme't) cannot be formylated. An (Fig. 4) . A single peak of mouse brain [l14CJfMet-tRNA Iet was eluted from the column at a higher salt concentration than the first isoaccepting methionyl-tRNA species. Since only tRNA that has been acylated with methionine can be formylated and E. coli enzymes can only acylate the methionine tRNA in the first peak from the RPC-5 column, it appears that the addition of a formyl group to Met-tRNAft has altered the chromatographic properties of this species. This alteration of the elution profile of Met-tRNAMf't after enzymic formylation to fMetMtRNAM et has previously been reported by Samuel et al. (1973) . It thus appears that the first species of mouse brain methionine tRNA eluted from the RPC-5 columns contains the initiator, tRNA,Ict, since this is the only species that can be acylated and formylated by E. coli enzymes.
Effects of phenylalanine on the acylation of the isoaccepting species ofmethionine tRNA The extent of acylation of each species of methionine tRNA was determined by separating the
[14C]Met-tRNA of the periodate-treated sample and the non-oxidized sample (total tRNA) of each tRNA preparation on individual RPC-5 columns. The amount ofradioactivity eluted in each peak was summed, and from these results the amount ofacylation of each isoaccepting species in vivo could be determined (Table 4) . As expected from the acylation of the total Met-tRNA (Table 3) , each of the three isoaccepting species of methionine tRNA in normal animals was highly acylated, usually 95-100 %. The acylation ofall three isoaccepting species from tRNA preparations isolated after the administration of phenylalanine was decreased. The acylation of the initiator species, tRNAfet (peak 1), wasdecreasedby9.5 %,whereas the other internal methionine tRNA species were both decreased by approx. 17% (18.3% for peak 2, 16.7% for peak 3) from the values measured in control preparations of tRNA isolated from mice injected with 0.15M-NaCl.
Discussion
The acute administration of phenylalanine has been demonstrated to induce the loss of several amino acids from neural tissue (Aoki & Siegel, 1970; Siegel et al., 1971; McKean et al., 1968; Hughes & Johnson, 1976a) . In particular, the amino acids that are co-transported with phenylalanine in brain tissue (i.e. leucine, isoleucine, methionine, tryptophan, tyrosine, valine) are most affected by high concentrations of phenylalanine. The large decreases in the intracellular concentrations of these amino acids may be explained by competition between phenylalanine and these other amino acids for transport into brain cells (Guroff & Udenfriend, 1962; Lindroos & Oja, 1971) , as well as by phenylalanine influencing the efflux of these amino acids from brain cells (Hughes & Johnson, 1976a) .
The altered intracellular concentrations of amino acids caused byhyperphenylalaninaemia has received much attention as a probable explanation for the inhibition of neural protein synthesis. Furthermore, as suggested by Appel (1970) and Roscoe et al. (1968) (Roscoe et al., 1968) . Until the development of the assays to determine the concentration of aminoacyl-tRNA in neural tissue in vivo (Johnson & Chou, 1973) , it has been difficult to evaluate the effects of phenylalanine on the aminoacylation of tRNA in vivo.
Despite the decreases in amino acids in neural tissue induced by hyperphenylalaninaemia, the proportion of the tRNA isolated as aminoacyl-tRNA actually increased for the tRNA molecules specific for some amino acids. For instance, although administration of phenylalanine decreases the intracellular concentration of alanine and lysine by 10-20 %, the proportion of tRNA present as aminoacyl-tRNA increases by 16.3% for alanine tRNA and 14.5% for lysine tRNA (Table 3) . Such an increase in the amount of acylation is the exact opposite of that expected if the hypothesis presented above is correct.
Since several investigators have indicated that the amino acid pools for the large neutral amino acids (those co-transported with phenylalanine) are even more substantially decreased during hyperphenylalaninaemia, the acylation of some of these amino acids was also determined. Although phenylalanine induces a loss of 40-50% of the intracellular leucine from the brain of young animals, the concentration of leucyl-tRNA actually increased by 14.1 % in vivo (Table 3) . Even though the effect of phenylalanine on the intracellular concentration of leucine is different from that seen with alanine and lysine, the increases in the proportion of aminoacyl-tRNA for these three amino acids is very similar.
The amino acid tryptophan has been demonstrated by several investigators (Sidransky et al., 1967; Pronczuk et al., 1968) to play a special role in polyribosome formation and in maintenance of the normal rate of protein synthesis, since its deletion from an animal's diet results in disaggregation of liver polyribosomes. In addition, after an intraperitoneal injection of phenylalanine, the kinetics of the loss of tryptophan from neural tissue has been Vol. 162 demonstrated to correlate well with the breakdown of polyribosomes and the inhibition of protein synthesis (Siegel et al., 1971) . The importance of this amino acid in maintaining the normal rate of protein synthesis may be emphasized by its presence at very low concentration in neural tissue (McKean et al., 1968) . Therefore tryptophan could represent a rate-limiting amino acid, whose concentration might influence the rate of protein synthesis. The present study indicates that, even though the intracellular concentration of tryptophan may be decreased by phenylalanine administration, the proportion of the tryptophan tRNA that is acylated is relatively unchanged (Tables 2 and 3 ).
In the light of the lower intracellular concentrations of several amino acids during hyperphenylalaninaemia, it is surprising that the concentration of aminoacyl-tRNA actually increases. This suggests that the concentration of the precursor aminoacyl-tRNA molecules are not directly correlated with amino acid concentrations. It also suggests that the action of phenylalanine on the protein-synthetic mechanism is not at the level of the aminoacylation of these particular tRNA molecules.
Since high concentrations of phenylalanine are known to inhibit protein synthesis, the increase in the concentration of aminoacyl-tRNA may actually be a reflection of this inhibition. For example, if an inhibitor of protein synthesis, such as phenylalanine, decreases the rate of protein synthesis or the number of ribosomes initiating on to and translating an mRNA molecule, then the rate of donation of an amino acid to the growing polypeptide on a ribosome would also be decreased. This would probably result in an increase in the proportion of tRNA that is present intracellularly as aminoacyl-tRNA. Indeed, the increase in the amounts of leucyl-tRNA, alanyl-tRNA and lysyltRNA may only be a secondary effect, resulting from the inhibition of protein synthesis caused by high concentrations of phenylalanine.
The concentration ofmethionyl-tRNA is, however, decreased during hyperphenylalaninaemia (Tables   2 and 3 ) with an average loss of 17%. In fact, when the methionyl-tRNA molecules are separated into the three isoaccepting species by reverse-phase chromatography, it was determined that high concentrations of phenylalanine decreased the acylation of all three methionine tRNA species. This suggested that high concentrations of phenylalanine may indeed affect the normal aminoacylation of all methionine tRNA species. The effect on the aminoacylation reaction in vivo might be due to either the methionine concentration falling to a rate-limiting value and or to high concentrations of phenylalanine directly inhibiting the synthetase specific for the acylation of methionine tRNA.
The effect of high concentrations of phenylalanine on the acylation of methionine tRNA is of particular importance because of the special role of methionyltRNA in cellular protein synthesis. In particular, one isoaccepting species, tRNAf et, is involved in the initiation complex for protein synthesis (Schreier & Staehelin, 1973; Gupta et al., 1975; Smith & Henshaw, 1975 ) and its intracellular concentration could possibly regulate the rate of protein synthesis.
The initiator species, tRNAf et, was identified in mouse brain tissue by the selective acylation and formylation of this single methionine tRNA species (Figs. 3 and 4 ) with E. coli enzymes. The selective acylation and formylation of the initiator, as well as the shift in elution pattern of the initiator after formylation, has been reported previously by several investigators for many different eukaryotic cell types (Crystal et al., 1972; Samuel et al., 1973; Stanley, 1972) . It thus appears that in mouse brain tissue the initiator, tRNA"et, is eluted first from the RPC-5 column, which is also consistent with the result of other investigators with eukaryotic cell types, using this chromatographic material (Crystal et al., 1972; Wang et al., 1974; Yang etal., 1969) .
In animals made hyperphenylalaninaemic, the concentration of acylated initiator, Met-tRNAf et, was demonstrated to be decreased by 9.5 % (Table 4) . The decrease in the acylation of tRNAf et is noteworthy in the light of the results of Taub & Johnson (1975) , which suggested that the phenylalanine-induced 'disaggregation' of polyribosomes may be due to a lowered rate of re-initiation of ribosomes. Thus the decrease in the aminoacylation of the tRNA species specific for the initiation of protein synthesis might be the site at which phenylalanine decreases the normal rate ofprotein synthesis.
The acylation of the other two isoaccepting species of methionine tRNA is also decreased by high concentrations of phenylalanine, apparently to an even greater extent, with an 18.3% (peak 2) and a 16.3% (peak 3) loss in aminoacyl-RNA concentration. Although the reason for the differential sensitivity of the isoaccepting species to high concentrations ofphenylalanine ispresently unknown, it does seem clear that the aminoacylation of all species of methionine tRNA is affected during hyperphenylalanaemia.
From the results presented in the studies by Taub & Johnson (1975) , Hughes & Johnson (1976a) and in the present study, a model could be proposed to explain the inhibition of protein synthesis detected after the administration of phenylalanine, which would include the following elements. (1) An alteration of the intracellular concentrations of most amino acids, and, in particular, a decrease in methionine and an increase in phenylalanine; (2) a decrease in the aminoacylation of methionine tRNA, and, especially, tRNAmCt, resulting from either loweredmethionine concentrations or increased phenylalanine concentrations that might be inhibitory to the aminoacylation reaction; (3) a decrease in initiation and in the number of ribosomes normally present in polyribosomes owing to a decrease in the amount of acylated tRNAfet; (4) a decrease in the normal rate of protein synthesis; (5) this decrease in the rate of synthesis would decrease the normal rate of aminoacyl-tRNA turnover, such that there would be an increase in the proportion of other tRNA molecules present as aminoacyl-tRNA (such as alanyl-tRNA, leucyl-tRNA etc.). This model suggests that methionine and tRNA, et may become rate-limiting for protein synthesis during hyperphenylalaninaemia. The model is supported by the demonstration that the 9.5 % decrease in the acylation of the initiator, tRNAf et, is compatible with the results of Taub & Johnson (1975) , in which it was reported that about 10% of the polyribosomes are disaggregated to monoribosomes as a result of a decreased rate of initiation.
Although Roberts & Morelos (1976) have suggested that brain polyribosome changes during hyperphenylalaninaemia may be a reflection of increased ribonuclease activity, the present study, along with the observarions Taub & Johnson (1975) , clearly shows that ribonuclease is not responsible. In addition, the hypothesis that brain polyribosome disaggregation is a reflection ofan amino acid imbalance, as described above, is supported by the re-formation ofbrain polyribosomes after the administration of a mixture of amino acids that includes methionine (Hughes & Johnson, 1976b) .
